Related Experiment Video
Updated: Mar 27, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Aspirin in dermatology: Revisited
1Department of Dermatology, Sri Ramachandra University, Chennai, Tamil Nadu, India.
Aspirin, a long-established medication, demonstrates significant benefits in dermatology, including a recently identified role in reducing melanoma risk. This highlights its expanding therapeutic applications beyond pain relief and cardiology.
Area of Science:
- Pharmacology
- Dermatology
- Oncology
Background:
- Aspirin is a widely recognized and historically significant medication.
- Its therapeutic applications have expanded considerably over time.
- Recent research suggests novel uses in dermatological conditions.
Purpose of the Study:
- To review the established and emerging applications of aspirin in dermatology.
- To highlight the potential of aspirin in mitigating melanoma risk.
- To underscore the evolving role of aspirin in medical treatment.
Main Methods:
- Literature review of existing studies on aspirin's dermatological applications.
- Analysis of recent research investigating aspirin and melanoma risk.
- Synthesis of evidence regarding aspirin's efficacy in various skin disorders.
Main Results:
- Aspirin has demonstrated efficacy in treating a range of dermatological disorders.
- Emerging evidence indicates a reduction in melanoma risk associated with aspirin use.
- The drug's utility is increasingly recognized in dermatology, complementing its established roles.
Conclusions:
- Aspirin possesses a broad spectrum of benefits in dermatological practice.
- The potential of aspirin in cancer chemoprevention, specifically for melanoma, warrants further investigation.
- Aspirin represents a versatile therapeutic agent with growing importance in skin health management.
Related Concept Videos
Acne Infection
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

